New research led by Queen Mary University of London reveals that unique DNA markings on certain genes may predict the risk of developing head and neck cancer.
Identifying the Disease Causing Mechanisms in Cancer Improves Treatment
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013) [1], will hear this.
Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013) [1], will hear this.
In this study scientists analysed clinical specimens of malignant tissue from 93 cancer patients from Norway and the UK. These were compared with either tissue donated by healthy individuals undergoing wisdom tooth extractions, or with non-cancerous tissue from the same patients.
They were trying to identify whether there were any epigenetic changes in the cancerous cells which were not seen in the healthy cells. Epigenetics is the study of changes in gene expression caused by mechanisms other than changes in the underlying DNA sequence.
Colorectal Cancer Incidence, Death, and All-Cause Mortality Lowered by Regular Primary Care Visits
New research indicates that regular primary care visits lower colorectal cancer incidence, death, and all-cause mortality.
New research indicates that regular primary care visits lower colorectal cancer incidence, death, and all-cause mortality.
Lead researcher Dr Muy Teck-Teh, from the Institute of Dentistry at Queen Mary, said: "In this study we have identified four genes which were either over or under-expressed in head and neck cancer. The expression of these genes was inversely correlated with particular DNA methylation marks, suggesting the genes are epigenetically modified in these cancers.
Advertisements
Blood Test Detected Cancer Metastasis, Says Study
Researchers have identified important similarities and differences between human and canine breast tumors.
Researchers have identified important similarities and differences between human and canine breast tumors.
"The eventual aim would be to test asymptomatic patients and/or people with unknown mouth lesions. An advantage of epigenetic DNA markers is that it may be possible to measure them using non-invasive specimens. So it could enable the use of saliva, buccal scrapes or blood serum for early cancer screening, diagnosis and prognosis."
Advertisements
Prostate Cancer Screening Test Does More Harm Than Good
Using the prostate-specific antigen (PSA) prostate cancer screening test is widely used in France despite a lack of evidence showing that it reduces cancer deaths.
Using the prostate-specific antigen (PSA) prostate cancer screening test is widely used in France despite a lack of evidence showing that it reduces cancer deaths.
"All of us mouth cancer surgeons want to catch the cancer early when the chances of cure are high and the effects of surgery on the patient are minimal. A simple test using the patient's blood or saliva could mean many patients with pre-cancer changes in the mouth or throat will be treated early and the cancer will never progress."
The study was partly funded by the research charity Saving Faces – The Facial Surgery Research Foundation. Professor Hutchison founded the charity, which aims to reduce facial injuries and diseases through medical research.
Source-Eurekalert
